Supreme Court unlikely to take up Coreg skinny label feud after Teva's $235M loss to GSK, lawyer says
3rd November 2022 Uncategorised 0 Supreme Court unlikely to take up Coreg skinny label feud after Teva’s $235M loss to GSK, lawyer says
fkansteiner
Thu, 11/03/2022 – 12:59
More: Supreme Court unlikely to take up Coreg skinny label feud after Teva's 5M loss to GSK, lawyer says
Source: fierce